Skip to main content
Signal8

Pangalos Menelas N

SEC insider (Form 3/4/5 filer). CIK 0002001873. Director at BIOGEN INC. (BIIB) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in VANCOUVER, WA.

Companies Pangalos Menelas N has filed insider reports for

  • BIOGEN INC. (BIIB): Director
  • Absci Corp (ABSI): Director
Pangalos Menelas N profile photo

Pangalos Menelas N

CIK: 0002001873

Transaction Breakdown

Open Market Buys (P)3 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (11.1%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BIOGEN INC. logo
BIIB

BIOGEN INC.

Director
Absci Corp logo
ABSI

Absci Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • BIOGEN INC. logo
    BIIB

    BIOGEN INC.

    Jun 9, 2026
    Award
    Direct
    1.5K shares-
  • BIOGEN INC. logo
    BIIB

    BIOGEN INC.

    Jun 9, 2026
    Exercise
    Direct
    2.4K shares-
  • Absci Corp logo
    ABSI

    Absci Corp

    Jun 4, 2026
    Award
    Direct
    10.1K shares-
  • Absci Corp logo
    ABSI

    Absci Corp

    May 13, 2026
    Purchase
    Direct
    37.5K shares at avg. $5.36$201K
  • Absci Corp logo
    ABSI

    Absci Corp

    Mar 2, 2026
    Award
    Direct
    5.8K shares-
  • Absci Corp logo
    ABSI

    Absci Corp

    Feb 27, 2026
    Purchase
    Direct
    75.1K shares at avg. $2.74$206K
  • Absci Corp logo
    ABSI

    Absci Corp

    Sep 22, 2025
    Purchase
    Direct
    95.8K shares at avg. $2.66$255K
  • BIOGEN INC. logo
    BIIB

    BIOGEN INC.

    Jun 17, 2025
    Award

    Restricted Stock Unit

    Direct
    2.4K shares-
  • Absci Corp logo
    ABSI

    Absci Corp

    Jun 11, 2025
    Award
    Direct
    14.5K shares-

1-9 of 9